StockData
Olema Oncology, Inc. logo

Olema Oncology, Inc. (OLMA) stock

OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$7.22−0.14 (-1.90%)

Close on Nov 17, 2026Market cap $631.73MP/E –Yield –

Olema Oncology cash

Cash and short-term investments held at the end of each period.

Olema Oncology's cash was $461.10M at Jun 30, 2026. For fiscal 2025 it was $505.40M, up 16.4% from the year before. The highest annual figure on record is $505.40M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$505.40M+16.4%
FY2024Dec 31, 2024$434.10M+65.8%
FY2023Dec 31, 2023$261.80M+28.1%
FY2022Dec 31, 2022$204.40M-28.9%
FY2021Dec 31, 2021$287.30M-15.1%
FY2020Dec 31, 2020$338.55M+497766.2%
FY2019Dec 31, 2019$68.00K-97.8%
FY2018Dec 31, 2018$3.15M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$461.10M+27.4%
Q1 FY2026Mar 31, 2026$505.30M+28.7%
Q4 FY2025Dec 31, 2025$505.40M+16.4%
Q3 FY2025Sep 30, 2025$329.00M+53.2%
Q2 FY2025Jun 30, 2025$361.90M+51.4%
Q1 FY2025Mar 31, 2025$392.70M+57.7%
Q4 FY2024Dec 31, 2024$434.10M+65.8%
Q3 FY2024Sep 30, 2024$214.80M-22.4%
Q2 FY2024Jun 30, 2024$239.10M+42.8%
Q1 FY2024Mar 31, 2024$249.00M+33.9%
Q4 FY2023Dec 31, 2023$261.80M+28.1%
Q3 FY2023Sep 30, 2023$276.90M+24.4%
Q2 FY2023Jun 30, 2023$167.40M-30.5%
Q1 FY2023Mar 31, 2023$186.00M-30.6%
Q4 FY2022Dec 31, 2022$204.40M-28.9%
Q3 FY2022Sep 30, 2022$222.60M-27.3%
Q2 FY2022Jun 30, 2022$240.70M-24.3%
Q1 FY2022Mar 31, 2022$267.90M-18.1%
Q4 FY2021Dec 31, 2021$287.30M-15.1%
Q3 FY2021Sep 30, 2021$306.00M+139.4%
Q2 FY2021Jun 30, 2021$318.10M+530.2%
Q1 FY2021Mar 31, 2021$327.00M+1071.7%
Q4 FY2020Dec 31, 2020$338.55M+497766.2%
Q3 FY2020Sep 30, 2020$127.82M+3959.2%
Q2 FY2020Jun 30, 2020$50.48M–
Q1 FY2020Mar 31, 2020$27.91M–
Q4 FY2019Dec 31, 2019$68.00K–
Q4 FY2018Dec 31, 2018$3.15M–

More Olema Oncology figures

See a number that looks wrong?